XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 33,336 $ 46,821
Accounts receivable, net 28,941 11,280
Prepaid expenses 7,773 7,773
Total Current Assets 70,050 65,874
Note receivable, net of discount of $4,716 and $0 as of December 31, 2022 and 2021, respectively 195,284 0
Intangible assets, net 248,585 298,085
Total Assets 513,919 363,959
Current Liabilities    
Accounts payable 133,408 161,171
Accrued liabilities 395,714 247,155
Deferred revenue 31,425 46,425
Unearned interest 5,151 0
Notes payable - current, net of discounts of $0 and $57,148 at December 31, 2022 and 2021, respectively 363,167 233,167
Shares payable to related parties 14,624 0
Salaries payable to related parties 263,516 273,926
Derivative liabilities 469,873 202,616
Total Current Liabilities 1,676,878 1,164,460
Notes payable 104,300 267,152
Due to stockholders 1,000 1,000
Total Liabilities 1,782,178 1,432,612
Commitments and Contingencies (Note 4)
Series B Convertible Preferred Stock, 600 shares designated, $0.001 Par Value, $1,200 stated value; 454 shares and 206 shares issued and outstanding at December 31, 2022 and 2021, respectively. Liquidation preference $544,800 and $247,200 as of December 31, 2022 and 2021, respectively 544,800 247,200
Stockholders' Equity (Deficit)    
Series A Preferred Stock, $0.001 par value, 10,000,000 Shares authorized; 25,845 shares issued and outstanding at December 31, 2022 and 2021, respectively 26 26
Common Stock $0.001 Par Value, 1,000,000,000 shares authorized; 352,174,583 shares and 220,254,395 shares issued and outstanding at December 31, 2022 and 2020, respectively 352,175 220,255
Additional paid in capital 7,141,877 7,008,098
Accumulated deficit (9,307,137) (8,544,232)
Total Stockholders' Equity (Deficit) (1,813,059) (1,315,853)
Total Liabilities and Stockholders' Equity (Deficit) $ 513,919 $ 363,959